Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

International Conference on Nanobiotechnology

Chicago, USA

Dar-Bin Shieh

Dar-Bin Shieh

National Cheng Kung University, Taiwan

Title: Fe3-δO4 nanoparticles inspired clinical therapeutics in cancer and Clostridium difficile infection

Biography

Biography: Dar-Bin Shieh

Abstract

Clostridium difficile infection (CDI) and cancer both are important causes of global healthcare cahllenges. Resistance of CD spores as well as cancer cells to various therapeutic measures post a significant threat. Nanomaterials have been explored for applications in anti-microbials as well as cancer therapy with intrinsic advantages of low drug-resistance issues and high efficacy. We discovered the 22 nm octahedral Fe3-δO4 single crystal nanoparticles with a strong saturation magnetization (94 emu/g) and exhibited inhibitory effect to CD spore germination in vitro and in vivo while at the same time serve as an excellent convertor for RF induced nano-heater for cancer hyperthermia therapy. The nanocrystal presented excellent MRI contrast effect and showed a dose dependent inhibition of CD spores germination (62% growth inhibition at 500 μg/mL) close to that of sodium hypochlorite. CDI animal model established in NF-κB-reporter mice presented significant bowel inflammation in the MOCK compared to Fe3-δO4 nanoparticles treated group as revealed by in vivo imaging system. Pro-inflammatory cytokines including IL-1β, TNF-α, and INF-γ and inflammatory cell infiltrations were significantly suppressed after nanoparticle treatment. In addition, the Fe3-δO4 nanoparticles (500 μg/mL) did not alter the microbiota and induce the liver or kidney damage in vivo. On the other hand, we observed significant anti-cancer efficacy upon integration of RF-hypertehrmia with synchronized thermal responsive chemotherapy in both in vitro and in vivo with complete tumor remission achieved with targeting add-on. These results provide nano-material based strategy for infection and cancer therapeutics that encourage further clinical translational development.